Home / Life Sciences

Legal News

MHRA announces closure of IDAP pilot phase

Copyright © 2025 LexisNexis

Published on: 04 April 2025

Published by LNB News

LNB News 04/04/2025

Document Information

Issue Date: 04 April 2025

Published Date: 04 April 2025

Jurisdiction(s): England, Northern Ireland, Scotland and Wales

Article summary

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the closure of the Innovative Devices Access Pathway (IDAP) pilot phase. The initiative selected eight medical technology companies to receive regulatory and access support through a Target Development Profile roadmap. The pathway, developed in partnership with NHS England and other healthcare bodies, aimed to accelerate development of innovative medical devices addressing unmet clinical needs in the NHS. Selected technologies include diagnostic tools for Alzheimer's disease, stroke identification, and cancer treatments.

Popular documents

If planning permission imposes restrictions on a licensed premises opening hours, once operational can

If planning permission imposes restrictions on a licensed premises opening hours, once operational can the personal licence holder apply for a Temporary Events Notice (TEN) to open for longer hours than those permitted in the planning permission?To use any property for a licensable activity both

What is the difference between an appeal and a review?

What is the difference between an appeal and a review?What is an appeal?An appeal in insolvency proceedings is no different to an appeal in normal litigation. An appeal will be allowed only if the appeal court is satisfied that the decision of the lower court was 'wrong' or 'unjust because of a

Financial clean break orders in family proceedings

Financial clean break orders in family proceedingsDuty of the court to consider a clean breakAlthough there is no presumption in favour of there being a financial clean break between parties on divorce, the court is under a duty to consider whether it would be appropriate to exercise its powers so

Where are misrepresentations made? Jurisdictional traps for the unwary (Bellmare Holdings Ltd v Wells)

Dispute Resolution analysis: The High Court has provided concise guidance as to how misrepresentation should be analysed when considering jurisdictional gateways. Under Article 5(3) of the Lugano Convention, in negligent misstatement cases, the place of the event giving rise to damage is normally